The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce ...

UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level ...

Commenting on the macroeconomic reality and its impact on the industrial sector, the Chartered Institute of Directors (CIoD) ...

The settlement, announced on Wednesday, resolves 93% of all Zantac cases in state courts against GlaxoSmithKline.

Antiviral Drugs MarketThe antiviral drugs market is anticipated to experience significant growth, flourishing at an average ...

Council bosses will reconsider their decision to move a library after concerns were raised over transparency of a ...

GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology ...

In a report released on October 10, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), ...

It’s the thing and agency dreads – the repitch. But this year there could be a bumper crop of repitches just around the ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a ...

The artificial intelligence (AI) market has created some monster growth stocks already, but companies involved in enabling ...